(kÄn'sÉr) 1  A disease characterized by any of various malignant neoplasms composed of abnormal cells that tend to proliferate rapidly and invade surrounding tissue. Without treatment such as chemotherapy or radiation, cancer cells can metastasize to other body sites and cause organ failure and death. 2  A malignant tumor.
Dosage and Administration (2.6, 2.7) 8/2016. Warnings and Precautions (5.10) 8/2016. INDICATIONS AND USAGE Gleevec is a kinase inhibitor indicated for the treatment of: Newly diagnosed adult and pediatric patients with Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in chronic phase (1.1)
Complete the form below to check eligibility for the GLEEVECÂ® (imatinib mesylate) $10 Co-Pay* Card. Eligible, commercially insured GLEEVEC patients pay only a $10 co-pay for a 30-day supply. Please note, patients taking a generic form of GLEEVEC are not eligible for the GLEEVEC $10 Co-Pay Card. Talk to your doctor about your options.